Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for BGMS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2003. Start Trial.
Date Value
June 30, 2026 7.854M
March 31, 2026 7.564M
December 31, 2025 8.185M
September 30, 2025 8.158M
June 30, 2025 4.401M
March 31, 2025 3.734M
December 31, 2024 4.094M
September 30, 2024 5.381M
June 30, 2024 8.19M
March 31, 2024 6.165M
December 31, 2023 8.805M
September 30, 2023 12.50M
June 30, 2023 16.44M
March 31, 2023 22.06M
December 31, 2022 28.05M
September 30, 2022 31.02M
June 30, 2022 35.35M
March 31, 2022 39.63M
December 31, 2021 42.59M
September 30, 2021 45.00M
June 30, 2021 46.33M
March 31, 2021 51.82M
December 31, 2020 36.80M
September 30, 2020 27.21M
June 30, 2020 29.17M
Date Value
March 31, 2020 12.99M
December 31, 2019 15.31M
September 30, 2019 17.08M
June 30, 2019 19.46M
March 31, 2019 21.51M
December 31, 2018 19.82M
September 30, 2018 20.71M
June 30, 2018 22.73M
March 31, 2018 24.78M
December 31, 2017 26.00M
September 30, 2017 27.85M
June 30, 2017 16.08M
March 31, 2017 17.07M
December 31, 2016 19.66M
September 30, 2016 22.65M
June 30, 2016 18.88M
March 31, 2016 21.46M
December 31, 2015 24.76M
September 30, 2015 27.05M
June 30, 2015 30.79M
March 31, 2015 35.36M
December 31, 2014 29.39M
September 30, 2014 31.63M
June 30, 2014 37.61M
March 31, 2014 33.78M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Supermax Corp. Bhd. 1.048B
YD Bio Ltd. 2.952M
ALPS Group, Inc. 1.740M
Cencora, Inc. 83.81B
ACADIA Pharmaceuticals, Inc. 1.743B

Total Assets (Quarterly) Related Metrics